TY - JOUR
T1 - Neurophysiological markers of response to theta burst stimulation in youth depression
AU - Dhami, Prabhjot
AU - Atluri, Sravya
AU - Lee, Jonathan
AU - Knyahnytska, Yuliya
AU - Croarkin, Paul E.
AU - Blumberger, Daniel M.
AU - Daskalakis, Zafiris J.
AU - Farzan, Faranak
N1 - Funding Information:
Prabhjot Dhami was supported by the doctoral award from Canadian Institute for Health Research (CIHR). Paul E. Croarkin has received research support from NIH (R01 MH113700), Mayo Clinic Foundation, and the Brain and Behavior Research Foundation. He has also received research support from Pfizer (investigator‐initiated study), Assurex (grant in kind for genotyping and supplies for investigator‐initiated study), and Neuronetics, Inc. (equipment support). He served as the overall PI for a multicenter trial funded by Neuronetics and site PI for a trial funded by NeoSync, Inc. He serves as an advisor to Procter and Gamble. Daniel M. Blumberger has received research support from the CIHR, NIH, Brain Canada and the Temerty Family through the CAMH Foundation and the Campbell Research Institute. He has also received research support and in‐kind equipment support for an investigator‐initiated study from Brainsway Ltd., and he is the principal site investigator for three sponsor‐initiated studies for Brainsway Ltd. He received in‐kind equipment support from Magventure for investigator‐initiated research. He received medication supplies for an investigator‐initiated trial from Indivior. He has participated in an advisory board for Janssen. Zafiris J. Daskalakis's work was supported by the Ontario Mental Health Foundation (OMHF), the Canadian Institutes of Health Research (CIHR), the National Institutes of Mental Health (NIMH), and the Temerty Family and Grant Family and through the Centre for Addiction and Mental Health (CAMH) Foundation, and the Campbell Institute. In the last 5 years, Zafiris J. Daskalakis has received research and equipment in‐kind support for an investigator‐initiated study through Brainsway Inc. and Magventure Inc. Faranak Farzan was supported by Michael Smith Foundation for Health Research Scholar Award (Award No. 17727), Slaight Family Centre for Youth in Transition, Natural Sciences and Engineering Research Council (RGPIN‐05783) and CIHR (Funding Reference No. 165863). Sravya Atluri, Jonathan C. Lee and Yuliya Knyahnytska have nothing to disclose.
Funding Information:
Dr. Croarkin has received research support from the Brain and Behavior Research Foundation, National Institute of Mental Health, Neuronetics, NeoSync, and Pfizer. He has received material support from and provided consultation to Myriad Genetics. He has consulted for Procter & Gamble Company.The remaining authors declare that there are no conflict of interests.
Publisher Copyright:
© 2020 Wiley Periodicals LLC
PY - 2021/2
Y1 - 2021/2
N2 - Background: Theta burst stimulation (TBS) has recently been proposed as a novel treatment for youth depression. However, the impact of TBS on the youth brain and neurophysiological predictors of response to TBS in this population have not been investigated. Methods: Cortical reactivity was assessed at baseline and following 2 weeks of bilateral dorsolateral prefrontal cortex (DLPFC) TBS treatment in 16 youth with depression (aged 16–24 years old). In 16 age-matched health youths, cortical reactivity was assessed twice, 2 weeks apart. Transcranial magnetic stimulation (TMS) combined with electroencephalography was used to assess TMS-evoked potentials in bilateral DLPFC, motor cortices, and intraparietal lobules (IPL). Resting-state functional magnetic resonance imaging (fMRI) data was also collected at baseline. Results: Left DLPFC pretreatment cortical reactivity, specifically the negativity at 45 ms (i.e., N45), which is related to GABAA neurotransmission, was associated with changes in depressive symptoms. Furthermore, TBS treatment was found to alter the N45 in the right IPL, a site distal to the treatment sites. The magnitude of the right IPL N45 modulation was correlated with the baseline fMRI connectivity between the right IPL and right DLPFC. Conclusions: TMS-probed cortical inhibition at the site of TBS application may have potential as a predictor of treatment response in youth depression. Furthermore, pre-treatment functional connectivity may predict the impact of TBS on the neurophysiology of regions distal to the stimulation site. Collectively, these results offer novel neurophysiological insights into the application of TBS for youth depression, which may facilitate its wider use in the youth population.
AB - Background: Theta burst stimulation (TBS) has recently been proposed as a novel treatment for youth depression. However, the impact of TBS on the youth brain and neurophysiological predictors of response to TBS in this population have not been investigated. Methods: Cortical reactivity was assessed at baseline and following 2 weeks of bilateral dorsolateral prefrontal cortex (DLPFC) TBS treatment in 16 youth with depression (aged 16–24 years old). In 16 age-matched health youths, cortical reactivity was assessed twice, 2 weeks apart. Transcranial magnetic stimulation (TMS) combined with electroencephalography was used to assess TMS-evoked potentials in bilateral DLPFC, motor cortices, and intraparietal lobules (IPL). Resting-state functional magnetic resonance imaging (fMRI) data was also collected at baseline. Results: Left DLPFC pretreatment cortical reactivity, specifically the negativity at 45 ms (i.e., N45), which is related to GABAA neurotransmission, was associated with changes in depressive symptoms. Furthermore, TBS treatment was found to alter the N45 in the right IPL, a site distal to the treatment sites. The magnitude of the right IPL N45 modulation was correlated with the baseline fMRI connectivity between the right IPL and right DLPFC. Conclusions: TMS-probed cortical inhibition at the site of TBS application may have potential as a predictor of treatment response in youth depression. Furthermore, pre-treatment functional connectivity may predict the impact of TBS on the neurophysiology of regions distal to the stimulation site. Collectively, these results offer novel neurophysiological insights into the application of TBS for youth depression, which may facilitate its wider use in the youth population.
KW - depression
KW - electrophysiology
KW - theta burst stimulation
KW - transcranial magnetic stimulation
KW - youth
UR - http://www.scopus.com/inward/record.url?scp=85091780805&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091780805&partnerID=8YFLogxK
U2 - 10.1002/da.23100
DO - 10.1002/da.23100
M3 - Article
C2 - 33001549
AN - SCOPUS:85091780805
SN - 1091-4269
VL - 38
SP - 172
EP - 184
JO - Depression and Anxiety
JF - Depression and Anxiety
IS - 2
ER -